Skip to main content
Premium Trial:

Request an Annual Quote

SomaLogic Raises $10M

NEW YORK (GenomeWeb News) – SomaLogic has raised $10 million in equity financing, the company said in a document filed with the US Securities and Exchange Commission on Tuesday.

The Boulder, Colo.-based protein biomarker discovery and clinical diagnostics company declined to comment on the financing. In its Form D document, it said that it had one investor in the round but did not identify the investor. SomaLogic did not say how proceeds will be used.

The privately held firm raised $19.5 million in 2003 in a Series C private financing round. In 2009, it received a $15 million investment from Quest Diagnostics as part of a diagnostic development deal, and in late 2003, SomaLogic received two investments totaling $11 million from two Japanese firms.

Last week, the company and Agilent Technologies announced a deal to expand SomaLogic's SOMAscan protein biomarker discovery platform.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.